RT Book, Section
A1 Badano, Luigi P.
A1 Pardo, Ana
A1 Muraru, Denisa
A1 Zamorano, Jose Luis
A2 Fuster, Valentin
A2 Narula, Jagat
A2 Vaishnava, Prashant
A2 Leon, Martin B.
A2 Callans, David J.
A2 Rumsfeld, John S.
A2 Poppas, Athena
SR Print(0)
ID 1202446123
T1 Acquired Tricuspid Valve Diseases
T2 Fuster and Hurst's The Heart, 15e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264257560
LK accesscardiology.mhmedical.com/content.aspx?aid=1202446123
RD 2024/04/24
AB Content  UpdateTRILUMINATE  Pivotal  TrialThe  TRILUMINATE  Pivotal  Trial  is  an  international  randomized  controlled  trial  of  tricuspid  transcatheter  edge-to-edge  repair  (TEER)  versus  medical  therapy  (control)  in  350  symptomatic  patients  with  severe  tricuspid  regurgitation  (TR)  with  mean  (±  SD)  age  78  ±  7  years  (55%  women).  Read  More